From Drug Benefit News - While PBMs have been giving significant attention to the rising cost of compounded medications (see story, above), another traditional category that’s driving trend at an alarming rate is diabetes. According to recent trend reports, PBMs observed double-digit increases in diabetes drug costs in 2013, largely due to inflation. Read more
From Drug Benefit News - While PBMs have begun making bold moves to manage the cost of compounded medications through coverage changes and even contract terminations (see story, p. 1), a new limited network has popped up that seeks to preserve these specialized medicines as a covered benefit by excluding the “players that have given the compounding industry a bad name.” United Compounding Network (UCN) is meant to be a closed, limited network that includes… Read more
From Drug Benefit News - Earlier this month, rumors of a possible sale of Humana Inc.’s PBM division began swirling after TheStreet.com said the insurer was evaluating strategic options for Humana Pharmacy Solutions and suggested that the PBM could be gobbled up for as much as $7 billion by Catamaran Corp., CVS Caremark Corp. or Express Scripts Holding Co. But while speaking at a recent health care conference, Humana President and CEO Bruce Broussard appeared… Read more
Check out all of the benefits, sample issues & more!